Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
BMC Cancer|May 27, 2017
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosisLaura Zanotti, Chiara Romani, Laura Tassone, et al.Cells|December 7, 2019
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric StudyEnrica Calura, Matteo Ciciani, Andrea Sambugaro, et al.Virology|January 5, 2005
Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Eliana Bignotti, et al.Cancer Letters|December 27, 2016
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohortsPaola Todeschini, Elisa Salviato, Lara Paracchini, et al.International Journal of Cancer|October 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 studyEliana Bignotti, Vittorio Simeon, Laura Ardighieri, et al.The International Journal of Biological Markers|November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trialStefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.International Journal of Cancer|February 26, 2020
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancerGiuseppe Benvenuto, Paola Todeschini, Lara Paracchini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric StudyPaolo Martini, Lara Paracchini, Giulia Caratti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificitiesEnrica Calura, Robert Fruscio, Lara Paracchini, et al.Journal of Experimental & Clinical Cancer Research : CR|April 11, 2023
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trialLuca Forlani, Loris De Cecco, Vittorio Simeon, et al.Pageof 8